Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis

Brain

Volumn 135, Issue 2, 2012, Pages 521-533

  Syc, Stephanie B ^a   Saidha, Shiv ^a   Newsome, Scott D ^a   Ratchford, John N ^a   Levy, Michael ^a   Ford, E'Tona ^a   Crainiceanu, Ciprian M ^b   Durbin, Mary K ^c   Oakley, Jonathan D ^c   Meyer, Scott A ^c   Frohman, Elliot M ^d   Calabresi, Peter A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c CARL ZEISS SMT AG   (Germany)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

demyelinating disease; multiple sclerosis; neuro ophthalmology; optic neuritis; optical coherence tomography; retinal segmentation

Indexed keywords

ARTICLE; AUTOMATION; AXONAL INJURY; CELL SWELLING; CONTROLLED STUDY; DISEASE ACTIVITY; EDEMA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NERVE CELL DEGENERATION; NERVE FIBER; NEUROIMAGING; NEUROPATHOLOGY; OPTIC NEURITIS; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; RETINA EXAMINATION; RETINA GANGLION CELL; RETINA INNER PLEXIFORM LAYER; RETINAL LAYER SEGMENTATION; VISION; VISION TEST;

EID: 84857223041     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awr264     Document Type: Article

References (44)

1. Axtell RC, de Jong BA, Boniface K, van der Voort LF, Bhat R, De Sarno P, et al. T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat Med 2010; 16: 406-12.
2. Balcer LJ. Clinical practice. Optic neuritis. N Engl J Med 2006; 354: 1273-80.
3. Barkhof F, Calabresi PA, Miller DH, Reingold SC. Imaging outcomes for neuroprotection and repair in multiple sclerosis trials. Nat Rev Neurol 2009; 5: 256-66.
4. Beck RW, Cleary PA. Optic neuritis treatment trial. One-year follow-up results. Arch Ophthalmol 1993; 111: 773-5. (Pubitemid 23170588)
5. Burkholder BM, Osborne B, Loguidice MJ, Bisker E, Frohman TC, Conger A, et al. Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis. Arch Neurol 2009; 66: 1366-72.
6. Costello F, Coupland S, Hodge W, Lorello GR, Koroluk J, Pan YI, et al. Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 2006; 59: 963-9. (Pubitemid 43830928)
7. Dawson WW, Maida TM, Rubin ML. Human pattern-evoked retinal responses are altered by optic atrophy. Invest Ophthalmol Vis Sci 1982; 22: 796-803. (Pubitemid 12051308)
8. Dutta R, Chang A, Doud MK, Kidd GJ, Ribaudo MV, Young EA, et al. Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients. Ann Neurol 2011; 69: 445-54.
9. Early Treatment Diabetic Retinopathy Study group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol, 1985, 103, 1796-806.
10. Fisher JB, Jacobs DA, Markowitz CE, Galetta SL, Volpe NJ, Nano-Schiavi ML, et al. Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology 2006; 113: 324-32. (Pubitemid 43170783)
11. Frohman EM, Frohman TC, Zee DS, McColl R, Galetta S. The neuro-ophthalmology of multiple sclerosis. Lancet Neurol 2005; 4: 111-21. (Pubitemid 40138926)
12. Frohman EM, Fujimoto JG, Frohman TC, Calabresi PA, Cutter G, Balcer LJ. Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol 2008; 4: 664-75.
13. Garas A, Simo M, Hollo G. Nerve fiber layer and macular thinning measured with different imaging methods during the course of acute optic neuritis. Eur J Ophthalmol 2011; 21: 473-83.
14. Giuliani F, Goodyer CG, Antel JP, Yong VW. Vulnerability of human neurons to T cell-mediated cytotoxicity. J Immunol 2003; 171: 368-79. (Pubitemid 36745310)
15. Green AJ, McQuaid S, Hauser SL, Allen IV, Lyness R. Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain 2010; 133: 1591-601.
16. Hee MR, Izatt JA, Swanson EA, Huang D, Schuman JS, Lin CP, et al. Optical coherence tomography of the human retina. Arch Ophthalmol 1995; 113: 325-32.
17. Henderson AP, Altmann DR, Trip AS, Kallis C, Jones SJ, Schlottmann PG, et al. A serial study of retinal changes following optic neuritis with sample size estimates for acute neuroprotection trials. Brain 2010; 133: 2592-602.
18. Hickman SJ, Dalton CM, Miller DH, Plant GT. Management of acute optic neuritis. Lancet 2002; 360: 1953-62. (Pubitemid 35472140)
19. Hickman SJ, Toosy AT, Jones SJ, Altmann DR, Miszkiel KA, MacManus DG, et al. A serial MRI study following optic nerve mean area in acute optic neuritis. Brain 2004; 127: 2498-505. (Pubitemid 39472978)
20. Hollander H, Bisti S, Maffei L, Hebel R. Electroretinographic responses and retrograde changes of retinal morphology after intracranial optic nerve section. A quantitative analysis in the cat. Exp Brain Res 1984; 55: 483-93. (Pubitemid 14085203)
21. Hood DC, Lin CE, Lazow MA, Locke KG, Zhang X, Birch DG. Thickness of receptor and post-receptor retinal layers in patients with retinitis pigmentosa measured with frequency-domain optical coherence tomography. Invest Ophthalmol Vis Sci 2009; 50: 2328-36.
22. Huang D, Swanson EA, Lin CP, Schuman JS, Stinson WG, Chang W, et al. Optical coherence tomography. Science 1991; 254: 1178-81. (Pubitemid 21917444)
23. Ikuta F, Zimmerman HM. Distribution of plaques in seventy autopsy cases of multiple sclerosis in the United States. Neurology 1976; 26: 26-8.
24. Kaufman D, Celesia GG. Simultaneous recording of pattern electroretinogram and visual evoked responses in neuro-ophthalmologic disorders. Neurology 1985; 35: 644-51. (Pubitemid 15067016)
25. Kerrison JB, Flynn T, Green WR. Retinal pathologic changes in multiple sclerosis. Retina 1994; 14: 445-51.
26. Nagelhus EA, Veruki ML, Torp R, Haug FM, Laake JH, Nielsen S, et al. Aquaporin-4 water channel protein in the rat retina and optic nerve: polarized expression in Muller cells and fibrous astrocytes. J Neurosci 1998; 18: 2506-19.
27. Naismith RT, Tutlam NT, Xu J, Klawiter EC, Shepherd J, Trinkaus K, et al. Optical coherence tomography differs in neuromyelitis optica compared with multiple sclerosis. Neurology 2009a; 72: 1077-82.
28. Naismith RT, Tutlam NT, Xu J, Shepherd JB, Klawiter EC, Song SK, et al. Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis. Neurology 2009b; 73: 46-52.
29. Pannicke T, Wurm A, Iandiev I, Hollborn M, Linnertz R, Binder DK. Deletion of aquaporin-4 renders retinal glial cells more susceptible to osmotic stress. J Neurosci Res 2010; 88: 2877-88.
30. Parisi V, Manni G, Spadaro M, Colacino G, Restuccia R, Marchi S, et al. Correlation between morphological and functional retinal impairment in multiple sclerosis patients. Invest Ophthalmol Vis Sci 1999; 40: 2520-7. (Pubitemid 29455479)
31. Perry VH, Lund RD. Evidence that the lamina cribrosa prevents intraretinal myelination of retinal ganglion cell axons. J Neurocytol 1990; 19: 265-72. (Pubitemid 20144697)
32. Pulicken M, Gordon-Lipkin E, Balcer LJ, Frohman E, Cutter G, Calabresi PA. Optical coherence tomography and disease subtype in multiple sclerosis. Neurology 2007; 69: 2085-92. (Pubitemid 350175711)
33. Ratchford JN, Quigg ME, Conger A, Frohman T, Frohman E, Balcer LJ, et al. Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology 2009; 73: 302-8.
34. Saidha S, Syc SB, Ibrahim MA, Eckstein C, Warner CV, Farrell SK, et al. Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 2011; 134: 518-33.
35. Seiple W, Price MJ, Kupersmith M, Siegel IM, Carr RE. The pattern electroretinogram in optic nerve disease. Ophthalmology 1983; 90: 1127-32. (Pubitemid 13010866)
36. Syc SB, Warner CV, Hiremath GS, Farrell SK, Ratchford JN, Conger A, et al. Reproducibility of high-resolution optical coherence tomography in multiple sclerosis. Mult Scler 2010; 16: 829-39.
37. Talman LS, Bisker ER, Sackel DJ, Long DA Jr, Galetta KM, Ratchford JN, et al. Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol 2010; 67: 749-60.
38. Tan O, Chopra V, Lu AT, Schuman JS, Ishikawa H, Wollstein G, et al. Detection of macular ganglion cell loss in glaucoma by Fourier-domain optical coherence tomography. Ophthalmology 2009; 116: 2305-14. e1-2.
39. Toussaint D, Perier O, Verstappen A, Bervoets S. Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis. J Clin Neuroophthalmol 1983; 3: 211-20. (Pubitemid 14229303)
40. Trip SA, Schlottmann PG, Jones SJ, Altmann DR, Garway-Heath DF, Thompson AJ. Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol 2005; 58: 383-91. (Pubitemid 41266624)
41. Wang T, Lee MH, Johnson T, Allie R, Hu L, Calabresi PA, et al. Activated T-cells inhibit neurogenesis by releasing granzyme B: rescue by Kv1.3 blockers. J Neurosci 2010; 30: 5020-7.
42. Williams RR, Cusato K, Raven MA, Reese BE. Organization of the inner retina following early elimination of the retinal ganglion cell population: effects on cell numbers and stratification patterns. Vis Neurosci 2001; 18: 233-44. (Pubitemid 32472429)
43. Wingerchuk DM, Weinshenker BG. Neuromyelitis optica: clinical predictors of a relapsing course and survival. Neurology 2003; 60: 848-53. (Pubitemid 36297372)
44. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-9. (Pubitemid 43958540)